AMAL MUTHANA: Open Payments
NPI 1053002238 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,294 in 35 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $1,189 · 2025 $1,294
Food & beverage: $1,195Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $332 |
| Incyte Corporation | 7 | $309 |
| Janssen Biotech, Inc. | 3 | $223 |
| GENZYME CORPORATION | 8 | $152 |
| Organon LLC | 2 | $130 |
| Lilly USA, LLC | 3 | $69 |
| UCB, Inc. | 1 | $44 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: OPZELURA, TREMFYA, SKYRIZI, DUPIXENT, BOTOX, VTAMA, TALTZ, Bimzelx.
Industry payments across CA — which companies pay providers there.
